Medicine and Dentistry
Prostate Cancer
100%
Castration Resistant Prostate Cancer
100%
Pemigatinib
100%
Cancer Cell
33%
Androgen Deprivation Therapy
33%
Androgen
33%
Enzalutamide
33%
Mediator
16%
Tumor Progression
16%
Cancer Growth
16%
Cancer Mortality
16%
Receptor
16%
Stroma
16%
Combination Therapy
16%
In Silico
16%
Cancer Prevention
16%
Tumor Growth
16%
Cancer Inhibition
16%
Cancer Recurrence
16%
Cell Death
16%
Growth Factor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Castration Resistant Prostate Cancer
100%
Pemigatinib
100%
Androgen
66%
Enzalutamide
33%
Neoplasm
16%
Receptor
16%
Combination Therapy
16%
Tumor Growth
16%
Growth Factor
16%
Cancer Growth
16%
Cancer Recurrence
16%
Cancer Mortality
16%
Cancer Inhibition
16%
INIS
cancer
100%
prostate
100%
castration
100%
androgens
30%
tumors
23%
therapy
15%
growth
15%
data
7%
implementation
7%
simulation
7%
humans
7%
in vivo
7%
interactions
7%
stochastic processes
7%
populations
7%
inhibition
7%
apoptosis
7%
mortality
7%
males
7%
receptors
7%
mice
7%
mathematical models
7%
growth factors
7%